Breaking: Vivos Therapeutics Strikes Deals; RPM Beats Wall Street Estimates
- October 04th, 2023
- 559 views
Shares of Vivos Therapeutics, Inc. (Nasdaq: VVOS) surged by more than 40% in pre-market trading following the announcement of strategic agreements with Ormco and On Demand Orthodontist. These agreements pave the way for Spark Clear Aligners to be offered within Vivos' national network of providers.
Vivos anticipates that these new relationships will not only bring potentially significant revenue opportunities for the company but also provide valuable airway-focused expertise. Additionally, Vivos-trained providers may benefit from potential cost savings.
$VVOS was trading at $0.27 in pre-market, marking a notable increase of $0.08 (+45.69%).
In other news, RPM International Inc. (NYSE: RPM) posted first-quarter fiscal 2024 earnings of $1.64 per share, surpassing the consensus EPS estimate of $1.55. The company's quarterly sales totaled $2.01 billion, exceeding analysts' revenue expectations of $1.97 billion.
In pre-market, $RPM was trading at $98.93, up $6.13 (6.61%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
What Wall Street Expects From Keysight, Mercury Systems, and Amer Sports: Earnings Preview
August 15th, 2026FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies
August 13th, 2026August 12th, 2026
Member Login